178 related articles for article (PubMed ID: 19632582)
21. Ventricular assist device-associated anti-human leukocyte antigen antibody sensitization in pediatric patients bridged to heart transplantation.
O'Connor MJ; Menteer J; Chrisant MR; Monos D; Lind C; Levine S; Gaynor JW; Hanna BD; Paridon SM; Ravishankar C; Kaufman BD
J Heart Lung Transplant; 2010 Jan; 29(1):109-16. PubMed ID: 20123248
[TBL] [Abstract][Full Text] [Related]
22. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD
J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946
[TBL] [Abstract][Full Text] [Related]
23. Lack of sensitization and equivalent post-transplant outcomes with the Novacor left ventricular assist device.
Baran DA; Gass AL; Galin ID; Zucker MJ; Arroyo LH; Goldstein DJ; Prendergast T; Lubitz S; Courtney MC; Correa R; Chan M; Spielvogel D; Lansman SL
J Heart Lung Transplant; 2005 Nov; 24(11):1886-90. PubMed ID: 16297796
[TBL] [Abstract][Full Text] [Related]
24. HLA sensitization in ventricular assist device recipients: does type of device make a difference?
Kumpati GS; Cook DJ; Blackstone EH; Rajeswaran J; Abdo AS; Young JB; Starling RC; Smedira NG; McCarthy PM
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1800-7. PubMed ID: 15173739
[TBL] [Abstract][Full Text] [Related]
25. Use of left ventricular assist device (HeartMate II): a Singapore experience.
Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
[TBL] [Abstract][Full Text] [Related]
26. Association of device surface and biomaterials with immunologic sensitization after mechanical support.
George I; Colley P; Russo MJ; Martens TP; Burke E; Oz MC; Deng MC; Mancini DM; Naka Y
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1372-9. PubMed ID: 18544389
[TBL] [Abstract][Full Text] [Related]
27. Increases in Serum Autoantibodies After Left Ventricular Assist Device Implantation.
Grosman-Rimon L; Ajrawat P; Lioe J; Tumiati LC; Rao V; Billia F; Chruscinski A
J Card Fail; 2019 Apr; 25(4):301-306. PubMed ID: 30630065
[TBL] [Abstract][Full Text] [Related]
28. Allosensitization does not alter post-transplant outcomes in pediatric patients bridged to transplant with a ventricular assist device.
Castleberry C; Zafar F; Thomas T; Khan MS; Bryant R; Chin C; Morales DL; Lorts A
Pediatr Transplant; 2016 Jun; 20(4):559-64. PubMed ID: 27102953
[TBL] [Abstract][Full Text] [Related]
29. The impact of Angiotensin II Type 1 Receptor antibodies on morbidity and mortality in Heart Mate II supported recipients.
Marian U; Slavcev A; Gazdic T; Ivak P; Netuka I
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Dec; 160(4):518-523. PubMed ID: 27132810
[TBL] [Abstract][Full Text] [Related]
30. Comparative cost-effectiveness of the HeartWare versus HeartMate II left ventricular assist devices used in the United Kingdom National Health Service bridge-to-transplant program for patients with heart failure.
Pulikottil-Jacob R; Suri G; Connock M; Kandala NB; Sutcliffe P; Maheswaran H; Banner NR; Clarke A
J Heart Lung Transplant; 2014 Apr; 33(4):350-8. PubMed ID: 24582838
[TBL] [Abstract][Full Text] [Related]
31. First series of left ventricular assist device exchanges to HeartMate 3.
Hanke JS; Rojas SV; Dogan G; Feldmann C; Beckmann E; Deniz E; Wiegmann B; Michaelis JE; Napp LC; Berliner D; Shrestha M; Bauersachs J; Haverich A; Schmitto JD
Eur J Cardiothorac Surg; 2017 May; 51(5):887-892. PubMed ID: 28329060
[TBL] [Abstract][Full Text] [Related]
32. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
[TBL] [Abstract][Full Text] [Related]
33. Immunologic sensitization in recipients of left ventricular assist devices.
John R; Lietz K; Schuster M; Naka Y; Rao V; Mancini DM; Rose EA; Smith CR; Oz MC; Edwards NM; Itescu S
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):578-91. PubMed ID: 12658200
[TBL] [Abstract][Full Text] [Related]
34. Human leukocyte antigen sensitization in pediatric patients exposed to mechanical circulatory support.
Hong BJ; Delaney M; Guynes A; Warner P; McMullan DM; Kemna MS; Boucek RJ; Law YM
ASAIO J; 2014; 60(3):317-21. PubMed ID: 24469294
[TBL] [Abstract][Full Text] [Related]
35. Association between homograft tissue exposure and allosensitization prior to heart transplant in patients with congenital heart disease.
Donovan DJ; Richmond ME; Bacha EA; Addonizio LJ; Zuckerman WA
Pediatr Transplant; 2022 May; 26(3):e14201. PubMed ID: 34889487
[TBL] [Abstract][Full Text] [Related]
36. HLA sensitization in pediatric pre-transplant cardiac patients supported by mechanical assist devices: the utility of Luminex.
Yang J; Schall C; Smith D; Kreuser L; Zamberlan M; King K; Gajarski R
J Heart Lung Transplant; 2009 Feb; 28(2):123-9. PubMed ID: 19201336
[TBL] [Abstract][Full Text] [Related]
37. Peri-operative alemtuzumab (Campath-1H) and plasmapheresis for high-PRA positive lymphocyte crossmatch heart transplant: a strategy to shorten left ventricular assist device support.
Lick SD; Vaidya S; Kollar AC; Boor PJ; Vertrees RA
J Heart Lung Transplant; 2008 Sep; 27(9):1036-9. PubMed ID: 18765198
[TBL] [Abstract][Full Text] [Related]
38. Outcomes after implantation of 139 full-support continuous-flow left ventricular assist devices as a bridge to transplantation.
Sabashnikov A; Mohite PN; Weymann A; Patil NP; Hedger M; Sáez DG; Zych B; Wahlers T; Wippermann J; De Robertis F; Bahrami T; Amrani M; Simon AR; Popov AF
Eur J Cardiothorac Surg; 2014 Nov; 46(5):e59-66. PubMed ID: 25180072
[TBL] [Abstract][Full Text] [Related]
39. B-cell activation and allosensitization after left ventricular assist device implantation is due to T-cell activation and CD40 ligand expression.
Schuster M; Kocher A; John R; Hoffman M; Ankersmit J; Lietz K; Edwards N; Oz M; Itescu S
Hum Immunol; 2002 Mar; 63(3):211-20. PubMed ID: 11872239
[TBL] [Abstract][Full Text] [Related]
40. The association of pretransplant HeartMate II left ventricular assist device placement and heart transplantation mortality.
Donneyong M; Cheng A; Trivedi JR; Schumer E; McCants KC; Birks EJ; Slaughter MS
ASAIO J; 2014; 60(3):294-9. PubMed ID: 24614355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
